Trial Profile
Effect of Sitagliptin on Myocardial function in type-2 diabetic patients complicated by congestive heart failure
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Heart failure; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Mar 2021 Status changed from recruiting to discontinued.
- 28 Jan 2014 New trial record